Ceribell Delirium Monitor System

FDA 510(k) K251936 · Ceribell, Inc.

Substantially Equivalent

510(k) numberK251936

Submission

Device name
Ceribell Delirium Monitor System
Applicant
Ceribell, Inc.
Sunnyvale, CA, US
Received
June 24, 2025
Decision date
December 8, 2025
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
NCG – Neuropsychiatric Interpretative Electroencephalograph Assessment Aid
Device class
Class II (moderate risk)
Regulation
21 CFR 882.1440
Specialty
Neurology

Uses a patient's electroencephalograph (EEG) to provide an interpretation of the patient's neuropsychiatric condition. It is also used only as an assessment aid for a medical condition for which there exists other valid methods of diagnosis."

Other 510(k)s with product code NCG

510(k)DeviceApplicantDecision
K222680DeltaScan MonitorNCG · Traditional Prolira B.V.02/02/2023SE

More from Prolira B.V.

510(k)DeviceDecision
K261101Ceribell MonitorOMC · Traditional 06/30/2026SE
K260998Ceribell Neurology Review SoftwareOMB · Traditional 06/24/2026SE
K260363Ceribell Brain Monitor HeadbandGXY · Abbreviated 04/03/2026SE
K254033Ceribell Instant EEG HeadsetGXY · Abbreviated 02/09/2026SE
K252070Ceribell Infant Seizure Detection SoftwareOMB · Traditional 11/21/2025SE
K251381Ceribell Instant EEG Headcap (Small: C251, Medium: C252)GXY · Abbreviated 10/31/2025SE
K241589Ceribell Seizure Detection SoftwareOMB · Traditional 04/09/2025SE
K232052Ceribell Instant EEG HeadbandGXY · Special 08/08/2023SE
K223504Ceribell Status Epilepticus MonitorOMB · Traditional 05/23/2023SE
K223086Ceribell Instant EEG HeadcapGXY · Abbreviated 03/22/2023SE

Questions and answers

When was Ceribell Delirium Monitor System cleared by the FDA?

Ceribell Delirium Monitor System (K251936) received a 510(k) decision of Substantially Equivalent on December 8, 2025, 167 days after the submission was received.

What is the product code of K251936?

The FDA product code is NCG – Neuropsychiatric Interpretative Electroencephalograph Assessment Aid, a Class II (moderate risk) device regulated under 21 CFR 882.1440.